Angiotensin converting enzyme inhibition ameliorates glomerular filtration of macromolecules and water and lessens glomerular injury in the rat

Andrea Remuzzi, Stefania Puntorieri, Cristina Battaglia, Tullio Bertani, Giuseppe Remuzzi

Research output: Contribution to journalArticle

240 Citations (Scopus)

Abstract

The effect of enalapril on glomerular hemodynamics and permselectivity and on subsequent sclerosis was studied in male MWF/Ztm rats which spontaneously develop proteinuria and glomerular structural damage. Untreated group 1 and enalapril-treated group 2 (50 mg/liter, in the drinking water) underwent micropuncture studies after 2 mo of observation. After the same period of treatment, group 3 (untreated) and group 4 (enalapril treated) were used for determination of whole-kidney function and neutral dextran clearances. Group 5 (untreated) and group 6 (enalapril treated) were followed for an additional 4 mo and used for kidney function and morphological studies. Enalapril significantly lowered systolic blood pressure, which was elevated in untreated groups, and significantly reduced proteinuria (295±64 vs. 128±24 mg/24 h by the end of the study). Despite the reduced renal perfusion pressure, whole-kidney glomerular filtration rate was higher in enalapril-treated than in untreated rats (0.96±0.14 vs. 0.81±0.10 ml/min, P <0.05) as was the single nephron glomerular filtration rate (54±7.1 vs. 46±4.0 nl/min, P <0.05). The single glomerular afferent plasma flow was comparable in both groups. Enalapril reduced mean glomerular capillary hydraulic pressure from the normal value of 51±1 mmHg (untreated rats) to a value lower than normal (44±1 mmHg, P <0.001). These hemodynamic changes were associated with a significant reduction in afferent (f=a 23%) and efferent (≈ 26%) arteriolar resistance. The mean ultrafiltration coefficient was two times higher in the enalapril (0.126±0.027 nl/s per mmHg) than in the untreated group (0.061±0.023 nl/s per mmHg). The clearance of dextran macromolecules relative to that of inulin was significantly reduced for all molecular sizes studied (26-64 Å) in enalapril-treated vs. untreated rats. Theoretical analysis of dextran fractional clearances using a heteroporous model of neutral solute transport across the glomerular capillary wall indicated that enalapril affected glomerular membrane size selective properties, reducing uniformly the radius of hypothetical membrane pores. Enalapril treatment also significantly limited (P <0.01) the development of glomerular structural lesions (mean percentage of sclerotic glomeruli was 4.2±3.5% [treated] vs. 28±15% [untreated] rats at the end of the study) as well as tubulo-interstitial damage. These results suggest that the protective effect of enalapril on the development of proteinuria and glomerular sclerosis in this model is due to its property of ameliorating size selectivity and hydraulic permeability of the glomerular capillaries.

Original languageEnglish
Pages (from-to)541-549
Number of pages9
JournalJournal of Clinical Investigation
Volume85
Issue number2
Publication statusPublished - Feb 1990

Fingerprint

Enalapril
Peptidyl-Dipeptidase A
Water
Wounds and Injuries
Dextrans
Proteinuria
Kidney
Sclerosis
Glomerular Filtration Rate
Reference Values
Hemodynamics
Blood Pressure
Pressure
Membranes
Inulin
Nephrons
Ultrafiltration
Capillary Permeability
Punctures
Drinking Water

Keywords

  • Angiotensin converting enzyme
  • Glomerular hemodynamics
  • Glomerulosclerosis
  • Proteinuria

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Angiotensin converting enzyme inhibition ameliorates glomerular filtration of macromolecules and water and lessens glomerular injury in the rat. / Remuzzi, Andrea; Puntorieri, Stefania; Battaglia, Cristina; Bertani, Tullio; Remuzzi, Giuseppe.

In: Journal of Clinical Investigation, Vol. 85, No. 2, 02.1990, p. 541-549.

Research output: Contribution to journalArticle

@article{53c54db771dd411783eb52953e79c7ee,
title = "Angiotensin converting enzyme inhibition ameliorates glomerular filtration of macromolecules and water and lessens glomerular injury in the rat",
abstract = "The effect of enalapril on glomerular hemodynamics and permselectivity and on subsequent sclerosis was studied in male MWF/Ztm rats which spontaneously develop proteinuria and glomerular structural damage. Untreated group 1 and enalapril-treated group 2 (50 mg/liter, in the drinking water) underwent micropuncture studies after 2 mo of observation. After the same period of treatment, group 3 (untreated) and group 4 (enalapril treated) were used for determination of whole-kidney function and neutral dextran clearances. Group 5 (untreated) and group 6 (enalapril treated) were followed for an additional 4 mo and used for kidney function and morphological studies. Enalapril significantly lowered systolic blood pressure, which was elevated in untreated groups, and significantly reduced proteinuria (295±64 vs. 128±24 mg/24 h by the end of the study). Despite the reduced renal perfusion pressure, whole-kidney glomerular filtration rate was higher in enalapril-treated than in untreated rats (0.96±0.14 vs. 0.81±0.10 ml/min, P <0.05) as was the single nephron glomerular filtration rate (54±7.1 vs. 46±4.0 nl/min, P <0.05). The single glomerular afferent plasma flow was comparable in both groups. Enalapril reduced mean glomerular capillary hydraulic pressure from the normal value of 51±1 mmHg (untreated rats) to a value lower than normal (44±1 mmHg, P <0.001). These hemodynamic changes were associated with a significant reduction in afferent (f=a 23{\%}) and efferent (≈ 26{\%}) arteriolar resistance. The mean ultrafiltration coefficient was two times higher in the enalapril (0.126±0.027 nl/s per mmHg) than in the untreated group (0.061±0.023 nl/s per mmHg). The clearance of dextran macromolecules relative to that of inulin was significantly reduced for all molecular sizes studied (26-64 {\AA}) in enalapril-treated vs. untreated rats. Theoretical analysis of dextran fractional clearances using a heteroporous model of neutral solute transport across the glomerular capillary wall indicated that enalapril affected glomerular membrane size selective properties, reducing uniformly the radius of hypothetical membrane pores. Enalapril treatment also significantly limited (P <0.01) the development of glomerular structural lesions (mean percentage of sclerotic glomeruli was 4.2±3.5{\%} [treated] vs. 28±15{\%} [untreated] rats at the end of the study) as well as tubulo-interstitial damage. These results suggest that the protective effect of enalapril on the development of proteinuria and glomerular sclerosis in this model is due to its property of ameliorating size selectivity and hydraulic permeability of the glomerular capillaries.",
keywords = "Angiotensin converting enzyme, Glomerular hemodynamics, Glomerulosclerosis, Proteinuria",
author = "Andrea Remuzzi and Stefania Puntorieri and Cristina Battaglia and Tullio Bertani and Giuseppe Remuzzi",
year = "1990",
month = "2",
language = "English",
volume = "85",
pages = "541--549",
journal = "Journal of Clinical Investigation",
issn = "0021-9738",
publisher = "The American Society for Clinical Investigation",
number = "2",

}

TY - JOUR

T1 - Angiotensin converting enzyme inhibition ameliorates glomerular filtration of macromolecules and water and lessens glomerular injury in the rat

AU - Remuzzi, Andrea

AU - Puntorieri, Stefania

AU - Battaglia, Cristina

AU - Bertani, Tullio

AU - Remuzzi, Giuseppe

PY - 1990/2

Y1 - 1990/2

N2 - The effect of enalapril on glomerular hemodynamics and permselectivity and on subsequent sclerosis was studied in male MWF/Ztm rats which spontaneously develop proteinuria and glomerular structural damage. Untreated group 1 and enalapril-treated group 2 (50 mg/liter, in the drinking water) underwent micropuncture studies after 2 mo of observation. After the same period of treatment, group 3 (untreated) and group 4 (enalapril treated) were used for determination of whole-kidney function and neutral dextran clearances. Group 5 (untreated) and group 6 (enalapril treated) were followed for an additional 4 mo and used for kidney function and morphological studies. Enalapril significantly lowered systolic blood pressure, which was elevated in untreated groups, and significantly reduced proteinuria (295±64 vs. 128±24 mg/24 h by the end of the study). Despite the reduced renal perfusion pressure, whole-kidney glomerular filtration rate was higher in enalapril-treated than in untreated rats (0.96±0.14 vs. 0.81±0.10 ml/min, P <0.05) as was the single nephron glomerular filtration rate (54±7.1 vs. 46±4.0 nl/min, P <0.05). The single glomerular afferent plasma flow was comparable in both groups. Enalapril reduced mean glomerular capillary hydraulic pressure from the normal value of 51±1 mmHg (untreated rats) to a value lower than normal (44±1 mmHg, P <0.001). These hemodynamic changes were associated with a significant reduction in afferent (f=a 23%) and efferent (≈ 26%) arteriolar resistance. The mean ultrafiltration coefficient was two times higher in the enalapril (0.126±0.027 nl/s per mmHg) than in the untreated group (0.061±0.023 nl/s per mmHg). The clearance of dextran macromolecules relative to that of inulin was significantly reduced for all molecular sizes studied (26-64 Å) in enalapril-treated vs. untreated rats. Theoretical analysis of dextran fractional clearances using a heteroporous model of neutral solute transport across the glomerular capillary wall indicated that enalapril affected glomerular membrane size selective properties, reducing uniformly the radius of hypothetical membrane pores. Enalapril treatment also significantly limited (P <0.01) the development of glomerular structural lesions (mean percentage of sclerotic glomeruli was 4.2±3.5% [treated] vs. 28±15% [untreated] rats at the end of the study) as well as tubulo-interstitial damage. These results suggest that the protective effect of enalapril on the development of proteinuria and glomerular sclerosis in this model is due to its property of ameliorating size selectivity and hydraulic permeability of the glomerular capillaries.

AB - The effect of enalapril on glomerular hemodynamics and permselectivity and on subsequent sclerosis was studied in male MWF/Ztm rats which spontaneously develop proteinuria and glomerular structural damage. Untreated group 1 and enalapril-treated group 2 (50 mg/liter, in the drinking water) underwent micropuncture studies after 2 mo of observation. After the same period of treatment, group 3 (untreated) and group 4 (enalapril treated) were used for determination of whole-kidney function and neutral dextran clearances. Group 5 (untreated) and group 6 (enalapril treated) were followed for an additional 4 mo and used for kidney function and morphological studies. Enalapril significantly lowered systolic blood pressure, which was elevated in untreated groups, and significantly reduced proteinuria (295±64 vs. 128±24 mg/24 h by the end of the study). Despite the reduced renal perfusion pressure, whole-kidney glomerular filtration rate was higher in enalapril-treated than in untreated rats (0.96±0.14 vs. 0.81±0.10 ml/min, P <0.05) as was the single nephron glomerular filtration rate (54±7.1 vs. 46±4.0 nl/min, P <0.05). The single glomerular afferent plasma flow was comparable in both groups. Enalapril reduced mean glomerular capillary hydraulic pressure from the normal value of 51±1 mmHg (untreated rats) to a value lower than normal (44±1 mmHg, P <0.001). These hemodynamic changes were associated with a significant reduction in afferent (f=a 23%) and efferent (≈ 26%) arteriolar resistance. The mean ultrafiltration coefficient was two times higher in the enalapril (0.126±0.027 nl/s per mmHg) than in the untreated group (0.061±0.023 nl/s per mmHg). The clearance of dextran macromolecules relative to that of inulin was significantly reduced for all molecular sizes studied (26-64 Å) in enalapril-treated vs. untreated rats. Theoretical analysis of dextran fractional clearances using a heteroporous model of neutral solute transport across the glomerular capillary wall indicated that enalapril affected glomerular membrane size selective properties, reducing uniformly the radius of hypothetical membrane pores. Enalapril treatment also significantly limited (P <0.01) the development of glomerular structural lesions (mean percentage of sclerotic glomeruli was 4.2±3.5% [treated] vs. 28±15% [untreated] rats at the end of the study) as well as tubulo-interstitial damage. These results suggest that the protective effect of enalapril on the development of proteinuria and glomerular sclerosis in this model is due to its property of ameliorating size selectivity and hydraulic permeability of the glomerular capillaries.

KW - Angiotensin converting enzyme

KW - Glomerular hemodynamics

KW - Glomerulosclerosis

KW - Proteinuria

UR - http://www.scopus.com/inward/record.url?scp=0025117505&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025117505&partnerID=8YFLogxK

M3 - Article

C2 - 1688888

AN - SCOPUS:0025117505

VL - 85

SP - 541

EP - 549

JO - Journal of Clinical Investigation

JF - Journal of Clinical Investigation

SN - 0021-9738

IS - 2

ER -